Trials / Completed
CompletedNCT00225524
Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.
Phase III Long-Term Administration Study of Effexor XR for the Treatment of Depression
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Phase III long-term safety study of Effexor XR in patients with major depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Effexor XR |
Timeline
- Start date
- 2004-09-01
- First posted
- 2005-09-23
- Last updated
- 2007-05-24
Locations
73 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00225524. Inclusion in this directory is not an endorsement.